Background – Low-molecular-weight heparin (LMWH) has been shown to reduce the
severity of postoperative inflammatory response. We decided to evaluate the specific effect of
intraoperative LMWH in reducing the severity of postoperative inflammatory response after
standard extracapsular cataract extraction and posterior chamber intraocular lens implantation
in cases of phacomorphic glaucoma.
Methods . In a randomized, double-blind, clinical trial, 46 eyes (23 case eyes and 23 control
eyes) were operated on by a single surgeon. In the first group, 5 IU/mL LMWH (Fragmin) was
added to the irrigating fluid. Intraoperative and postoperative hemorrhage, degree of
postoperative inflammation, fibrin and posterior synechiae formation, pigment deposits on the
intraocular lens surface, visual acuity and intraocular pressure (IOP) were evaluated. The control
group underwent a routine conventional surgery.
Results – The mean age was 68 years (standard deviation, 8.1; range, 63 . 79 yr). No
statistically significant difference in age, sex, duration of operation and hospitalization,
preoperative IOP, concurrent ocular and systemic illness, or smoking was found between the
cases and controls. There was a statistically significant difference between the two groups in
terms of density of cell and flare in anterior chamber, fibrin formation, pigment deposition over
intraocular structure, and severity of postoperative inflammation. There was also a statistically
significant difference in postoperative visual acuity between cases and controls (20/50 vs
20/125, respectively; p = 0.001). The incidences of intra- and postoperative hemorrhage were
similar between the two groups (p = 1.0).
Conclusion – LMWH can be used safely in patients with phacomorphic glaucoma. In this
study, it was positively correlated with reduced postoperative inflammation and fibrin formation,
and gave rise to better visual acuity.